Market Price

1.27 

0.00 -0.4%

as of May 18 '22

52 Week Range:

1.20 1.90


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. The company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. It offers products in the areas of active living-immune system and sports, healthy living–brain and heart, and starting out-infant and child. The company was founded in 1988 and is headquartered in Altona North, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18 Jul '19 Jul '20 Jul '21
Equity (BVPS) 0.17
0.18
0.18
0.19
0.18
0.18
0.18
0.21
0.25
0.29
0.34
growth rate 5.9% 0.0% 5.6% -5.3% 0.0% 0.0% 16.7% 19.1% 16.0% 17.2%
Earnings BIT 6.13
6.36
8.00
1.29
-0.08
2.83
5.49
9.95
13.59
18.36
9.52
growth rate 3.8% 25.8% -83.9% -100.0% 100.0% 93.9% 81.3% 36.5% 35.2% -48.2%
Avg.PE 11.80
15.38
14.95
63.33
260.00
46.15
29.67
33.91
38.33
34.26
23.23
growth rate 30.3% -2.8% 323.6% 310.6% -82.3% -35.7% 14.3% 13.0% -10.6% -32.2%
ROA 14.20
12.24
15.09
2.39
0.26
5.79
8.83
16.03
15.93
15.98
7.49
growth rate -13.8% 23.3% -84.2% -89.1% 2,126.9% 52.5% 81.5% -0.6% 0.3% -53.1%
ROE 16.40
15.08
19.51
3.09
0.34
7.43
11.59
21.46
24.26
24.32
10.35
growth rate -8.1% 29.4% -84.2% -89.0% 2,085.3% 56.0% 85.2% 13.1% 0.3% -57.4%
ROIC 14.24
19.03
2.80
0.16
7.24
11.48
19.15
20.47
19.73
8.70
growth rate 33.6% -85.3% -94.3% 4,425.0% 58.6% 66.8% 6.9% -3.6% -55.9%
Cur. Ratio 3.62
4.01
3.59
4.23
3.51
3.79
4.29
3.15
5.40
6.98
growth rate 10.8% -10.5% 17.8% -17.0% 8.0% 13.2% -26.6% 71.4% 29.3%
Quick Ratio 2.23
2.34
1.75
2.15
2.03
1.82
2.28
1.52
2.38
2.85
growth rate 4.9% -25.2% 22.9% -5.6% -10.3% 25.3% -33.3% 56.6% 19.8%
Leverage 1.31
1.28
1.31
1.24
1.32
1.30
1.36
1.66
1.42
1.35
growth rate -2.3% 2.3% -5.3% 6.5% -1.5% 4.6% 22.1% -14.5% -4.9%
Balance Sheet Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18 Jul '19 Jul '20 Jul '21
Acct.Receivable 10.00
10.00
12.00
8.06
5.45
10.87
12.13
15.26
18.45
16.78
13.70
growth rate 0.0% 20.0% -32.8% -32.3% 99.3% 11.6% 25.8% 20.9% -9.0% -18.4%
Acct.Payable 3.00
7.00
7.00
6.29
4.60
5.10
8.92
5.98
7.97
6.30
4.92
growth rate 133.3% 0.0% -10.1% -27.0% 10.9% 75.0% -32.9% 33.1% -21.0% -21.9%
Cur.Assets 27.00
32.00
35.00
32.91
29.47
33.10
37.62
43.58
55.36
59.07
54.74
growth rate 18.5% 9.4% -6.0% -10.4% 12.3% 13.6% 15.8% 27.0% 6.7% -7.3%
Total Assets 32.00
39.00
41.00
39.50
36.56
39.82
42.64
52.05
74.75
81.49
78.73
growth rate 21.9% 5.1% -3.7% -7.4% 8.9% 7.1% 22.1% 43.6% 9.0% -3.4%
Cash 7.00
10.00
8.00
8.03
9.55
8.23
5.92
7.89
8.27
9.24
9.09
growth rate 42.9% -20.0% 0.4% 19.0% -13.8% -28.1% 33.4% 4.8% 11.7% -1.6%
Inventory 9.00
12.00
14.00
16.50
14.18
13.63
18.81
19.77
27.68
31.93
30.78
growth rate 33.3% 16.7% 17.9% -14.1% -3.8% 38.0% 5.1% 40.0% 15.4% -3.6%
Cur.Liabilities 4.00
9.00
9.00
9.16
6.98
9.43
9.92
10.15
17.56
10.94
7.84
growth rate 125.0% 0.0% 1.7% -23.8% 35.1% 5.2% 2.3% 73.1% -37.7% -28.3%
Liabilities 4.00
9.00
9.00
9.36
7.17
9.61
10.07
13.91
29.61
23.92
20.32
growth rate 125.0% 0.0% 4.0% -23.4% 34.0% 4.8% 38.2% 112.9% -19.2% -15.1%
LT Debt 0.00
0.20
0.00
3.74
11.99
12.90
11.45
growth rate -100.0% 220.7% 7.7% -11.2%
Equity 28.07
29.90
32.40
30.13
29.39
30.21
32.58
38.15
45.14
57.57
58.42
growth rate 6.5% 8.4% -7.0% -2.5% 2.8% 7.8% 17.1% 18.3% 27.5% 1.5%
Common Shares 165.18
165.00
165.00
165.00
165.00
165.00
165.00
165.00
166.00
168.00
166.00
growth rate -0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 1.2% -1.2%
Cash Flow Statement Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18 Jul '19 Jul '20 Jul '21
Capital Expenditures 0.55
2.00
1.00
0.18
0.76
0.02
0.48
4.23
0.11
0.56
1.83
growth rate 263.6% -50.0% -82.0% 321.1% -97.5% 2,426.3% 780.4% -97.4% 414.8% 229.3%
Cash Dividends 2.07
2.50
3.70
3.30
0.83
1.24
1.24
2.07
3.10
2.91
4.99
growth rate 20.8% 48.0% -10.7% -75.0% 50.0% 0.0% 66.7% 50.0% -6.0% 71.4%
Cash From OA -2.11
8.00
3.00
3.20
3.11
-0.06
-0.60
4.08
4.79
6.66
8.23
growth rate 100.0% -62.5% 6.6% -2.9% -100.0% 0.0% 100.0% 17.4% 39.0% 23.5%
FCF per Share 0.04
0.04
0.02
-0.01
0.01
0.02
-0.03
0.02
0.09
growth rate 0.0% -50.0% -100.0% 100.0% 100.0% -100.0% 100.0% 112.1%
FCF -2.66
6.00
2.00
3.00
2.00
-0.08
-1.00
-0.15
5.00
6.00
6.00
growth rate 100.0% -66.7% 50.0% -33.3% -100.0% 0.0% 0.0% 100.0% 20.0% 0.0%
Income Statement Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18 Jul '19 Jul '20 Jul '21
Sales 33.00
38.00
44.00
27.19
29.92
42.92
47.86
62.96
76.68
88.28
60.51
growth rate 15.2% 15.8% -38.2% 10.0% 43.4% 11.5% 31.5% 21.8% 15.1% -31.5%
Op.Income 4.00
4.00
8.00
1.29
-0.08
2.83
5.49
9.95
13.59
18.36
9.52
growth rate 0.0% 100.0% -83.9% -100.0% 100.0% 93.9% 81.3% 36.5% 35.2% -48.2%
IBT 6.13
6.40
8.50
1.23
0.00
3.11
5.01
10.62
13.96
17.66
8.18
growth rate 4.4% 32.8% -85.5% -99.7% 77,600.0% 61.3% 111.8% 31.5% 26.4% -53.7%
Net Income 4.00
4.00
6.00
0.97
0.10
2.21
3.64
7.59
10.10
12.49
6.00
growth rate 0.0% 50.0% -83.9% -89.7% 2,113.0% 64.4% 108.5% 33.1% 23.6% -51.9%
EPS 0.03
0.02
0.04
0.01
0.01
0.02
0.05
0.06
0.07
0.04
growth rate -33.3% 100.0% -75.0% 0.0% 100.0% 150.0% 20.0% 16.7% -42.9%
Gross Profit 13.00
15.00
15.00
7.92
6.04
8.66
11.59
18.25
23.92
29.72
18.24
growth rate 15.4% 0.0% -47.2% -23.7% 43.4% 33.7% 57.5% 31.1% 24.2% -38.6%
R&D 1.50
1.80
1.92
1.60
1.16
1.11
1.52
1.75
2.20
1.79
growth rate 20.0% 6.8% -16.9% -27.3% -4.2% 36.4% 15.3% 25.4% -18.4%

Quarterly Statements

Item Name Jul '20 Oct '20 Jan '21 Apr '21 Jul '21
Earnings BIT 6.04
2.18
2.18
2.58
2.58
growth rate -63.9% 0.0% 18.3% 0.0%
Balance Sheet Jul '20 Oct '20 Jan '21 Apr '21 Jul '21
Acct.Receivable 16.78
9.65
9.65
13.70
13.70
growth rate -42.5% 0.0% 41.9% 0.0%
Acct.Payable 6.30
4.19
4.19
4.92
4.92
growth rate -33.4% 0.0% 17.3% 0.0%
Cur.Assets 59.07
52.13
52.13
54.74
54.74
growth rate -11.8% 0.0% 5.0% 0.0%
Total Assets 81.49
74.63
74.63
78.73
78.73
growth rate -8.4% 0.0% 5.5% 0.0%
Cash 9.24
9.82
9.82
9.09
9.09
growth rate 6.2% 0.0% -7.4% 0.0%
Inventory 31.93
31.54
31.54
30.78
30.78
growth rate -1.2% 0.0% -2.4% 0.0%
Cur.Liabilities 10.94
6.52
6.52
7.84
7.84
growth rate -40.4% 0.0% 20.2% 0.0%
Liabilities 23.92
18.73
18.73
20.32
20.32
growth rate -21.7% 0.0% 8.5% 0.0%
LT Debt 12.90
12.15
12.15
11.45
11.45
growth rate -5.8% 0.0% -5.8% 0.0%
Equity 57.57
55.90
55.90
58.42
58.42
growth rate -2.9% 0.0% 4.5% 0.0%
Common Shares 35.37
35.37
35.37
35.60
35.60
growth rate 0.0% 0.0% 0.7% 0.0%
Cash Flow Statement Jul '20 Oct '20 Jan '21 Apr '21 Jul '21
Capital Expenditures 0.03
0.40
0.40
0.51
0.51
growth rate 1,287.9% 0.0% 27.5% 0.0%
Cash Dividends 2.08
2.08
2.08
0.42
0.42
growth rate 0.0% 0.0% -80.0% 0.0%
Cash From OA 5.11
3.21
3.21
0.91
0.91
growth rate -37.3% 0.0% -71.7% 0.0%
FCF 5.08
2.80
2.80
0.39
0.39
growth rate -44.8% 0.0% -86.0% 0.0%
Income Statement Jul '20 Oct '20 Jan '21 Apr '21 Jul '21
Sales 25.33
14.72
14.72
15.53
15.53
growth rate -41.9% 0.0% 5.5% 0.0%
Op.Income 6.04
2.18
2.18
2.58
2.58
growth rate -63.9% 0.0% 18.3% 0.0%
IBT 5.65
1.65
1.65
2.44
2.44
growth rate -70.8% 0.0% 48.1% 0.0%
Net Income 3.93
1.26
1.26
1.75
1.75
growth rate -68.0% 0.0% 39.0% 0.0%
Gross Profit 8.97
4.50
4.50
4.62
4.62
growth rate -49.9% 0.0% 2.7% 0.0%
R&D 0.67
0.61
0.61
0.29
0.29
growth rate -9.8% 0.0% -52.1% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (55.08)

YOY Growth Grade:

D (45.73)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 35.83 35.28 18.43
EPS / Growth 95.0% 0.04 34.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.5% 22.4% 22.4%
Future PE 18.43 33.03 33.03
Future EPS 0.10 0.27 0.27
Value Price
MOS %
0.45
-64.9%
2.22
75.0%
2.22
75.0%
MOS Price 0.22 1.11 1.11
IRT 14.70 9.93 9.93

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.